Download presentation
Presentation is loading. Please wait.
Published byBrynjar Dale Modified over 5 years ago
1
Long-term survival after pediatric cardiac transplantation and postoperative ECMO support
Kathleen N Fenton, MD, Steven A Webber, MD, David A Danford, MD, Sanjiv K Gandhi, MD, Jayson Periera, MD, Frank A Pigula, MD The Annals of Thoracic Surgery Volume 76, Issue 3, Pages (September 2003) DOI: /S (03)
2
Fig 1 Early and late use of extracorporeal membrane oxygenation (ECMO) after pediatric cardiac transplant (slashed bars = total number of patients placed in ECMO in each group; open bars = decannulated; solid bars = discharged). The Annals of Thoracic Surgery , DOI: ( /S (03) )
3
Fig 2 Indications for extracorporeal membrane oxygenation in early (shaded bars) and late (slashed bars) groups. (ACR = acute cellular rejection; Arrest = sudden cardiac arrest; GF = graft failure; MOF = multiorgan failure; Pulm = pulmonary failure; PVR = elevated pulmonary vascular resistance.) The Annals of Thoracic Surgery , DOI: ( /S (03) )
4
Fig 3 Effect of date on extracorporeal membrane oxygenation (ECMO) use and survival (solid bars = number treated; slashed bars = number of patients undergoing ECMO; open bars = survivors). The Annals of Thoracic Surgery , DOI: ( /S (03) )
5
Fig 4 Effect of extracorporeal membrane oxygenation (ECMO) indication on outcome (slashed bars = total; solid bars = decannulated; dotted bars = discharged; open bars = alive 5.6 months to 9.8 years after ECMO). (ACR = acute cellular rejection; Arrest = sudden cardiac arrest; GF = graft failure; MOF = multiorgan failure; Pulm = pulmonary failure; PVR = elevated pulmonary vascular resistance.) The Annals of Thoracic Surgery , DOI: ( /S (03) )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.